SCHEMBL1661528

SCHEMBL1661528

Cc1ccc(-c2nc3ccc(C=Cc4ccccc4)nc3s2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 4/20 0.46
HPGD P15428 3/20 0.46
NPC1 O15118 3/20 0.46
NFKB1 P19838 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
S1PR1 P21453 10/20 0.43
EGFR P00533 1/20 0.39
PKM P14618 2/20 0.39
GRM5 P41594 1/20 0.39
GRM4 Q14833 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1662329 0.76 KDM4E (0.50) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL1661523 0.75 S1PR1 (0.45) S1PR1S1PR3
SCHEMBL9169404 0.73 KDM4E (0.70) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL1663822 0.73 S1PR1 (0.71) S1PR1S1PR3
SCHEMBL29021923 0.71 KDM4E (0.72) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL1661384 0.71 S1PR1 (0.63) S1PR1S1PR3
SCHEMBL1987260 0.69 MAPT (0.63) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL2195913 0.69 MAPT (0.63) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL27536788 0.68 SMN1; SMN2 (0.46) KDM4EALDH1A1RAB9AHPGDNPC1
SCHEMBL12884277 0.66 RAB9A (0.68) KDM4EALDH1A1RAB9AHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP disclosed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO disclosed